We develop novel CAR-T cells, oncolytic viruses and viral vectors to induce bystander immunity and reshape the tumour microenvironment and improve immunotherapy

ID: 1687017592945332224

linkhttps://www.igp.uu.se/research/cancer-immunotherapy/magnus-essand/ calendar_today03-08-2023 08:28:51